HIMS is trading at $29.73 (+5.18%) as investors position ahead of its Q1 2026 earnings report, scheduled for release after the market close on May 11.
- Analysts are forecasting revenue of $616.9M and EPS of $0.04, with significant investor focus on potential updates regarding the company's weight-loss segment.
- The stock is significantly outperforming the broader market (S&P 500 +0.22%) despite recent volatility, including a 10% gain on May 8 that followed a 5% drop the prior day.